ロード中...
Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease
A protein biomarker discovery workflow was applied to plasma samples from patients at different stages of diabetic kidney disease. The proteomics platform produced a panel of significant plasma biomarkers that were statistically scrutinised against the current gold standard tests on an analysis of 5...
保存先:
| 出版年: | EuPA Open Proteom |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5988498/ https://ncbi.nlm.nih.gov/pubmed/29900119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euprot.2016.12.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|